Showing results (11-20 of 103) with videos related to
Sort By:
Pageof 11
Bioengineering (Basel, Switzerland)|December 23, 2023
Improved Hypertension Risk Assessment with Photoplethysmographic Recordings Combining Deep Learning and CalibrationJesús Cano, Vicente Bertomeu-González, Lorenzo Fácila, et al.Medicina Clinica|May 5, 2016
[Use of the CHADS2 score as a predictor of the risk of mortality in hypertensive patients. The FAPRES study]Elena Castilla, Pedro Morillas, Manuel Gómez, et al.Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|December 7, 2006
[Prognostic impact of anemia in acute heart failure]Luciano Consuegra-Sánchez, Julio Núñez, Lorenzo Fácila, et al.Journal of Personalized Medicine|March 25, 2022
The Dissimilar Impact in Atrial Substrate Modificationof Left and Right Pulmonary Veins Isolation after Catheter Ablation of Paroxysmal Atrial FibrillationAikaterini Vraka, Vicente Bertomeu-González, Lorenzo Fácila, et al.Biosensors|May 28, 2022
The Relevance of Calibration in Machine Learning-Based Hypertension Risk Assessment Combining Photoplethysmography and ElectrocardiographyJesús Cano, Lorenzo Fácila, Juan M Gracia-Baena, et al.Revista Espanola De Cardiologia|March 10, 2009
Importance of recognizing occult renal disease in hypertensive patientsLorenzo Fácila, Vicente Bertomeu-González, Vicente Bertomeu, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|June 17, 2009
Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA studyLorenzo Fácila, Vicente Bertomeu, Vicente Bertomeu-González, et al.Revista Portuguesa De Cardiologia|June 24, 2018
18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditisVerónica Vidal, Cristina Albiach, Josep Gradolí, et al.Revista Espanola De Cardiologia|September 3, 2011
[How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study]Xavier Garcia-Moll, Lorenzo Fácila, Pedro Conthe, et al.International Journal of Cardiology|February 3, 2005
Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteineVicent Bodí, Juan Sanchis, Angel Llàcer, et al.Pageof 11